Cancer Scientists Archives - NFCR

Cancer Scientists

Hormone Therapy: Influencing Breast Cancer Treatment and Beyond

While recent medical discoveries, from drugs to imaging techniques, continue to revolutionize cancer care, none of them would be possible without foundations having been laid years, or even decades, earlier. Groundbreaking work by the late endocrinologist Jack Gorski, Ph.D., who passed away in 2006 and was funded by the National…...

Read more

In Remembrance of Dr. Aaron Klug

       The National Foundation for Cancer Research remembers and recognizes the contributions of Aaron Klug, Ph.D., who passed away on November 20, 2018, at the age of 92. Born in Lithuania to a Jewish family in 1926, Aaron Klug grew up in South Africa and moved to the…...

Read more

Dr. John Schiller Discusses the Power of NFCR Funding

Dr. Schiller and Dr. Lowy’s work is made possible through funding from foundations like NFCR that support innovative outside the box research responsible for major medical discoveries. See why Dr. Schiller thinks funding a wider range of research has the possibility of making a big impact.  ...

Read more

Liquid Biopsy Advances: Capturing Metastatic Cancer Cells

A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientists supported by the National Foundation for Cancer Research since 2003, the business card-sized…...

Read more

Dr. Doug Lowy on the Future of Cancer Research

Dr. Lowy, in collaboration with Dr. John Schiller, has been awarded the 2018 Szent-Györgyi prize for Progress in Cancer Research for their development of a preventive vaccine for human papilloma virus, which is the leading cause of cervical cancer cases. See why Dr. Lowy thinks that the problems with cancer…...

Read more

Artemisinin Therapies: Connecting the Dots

You wouldn’t think it, but the science cannot be denied: One of the newest and most promising drug candidates for cancer was actually developed all the way back in 1972. For malaria. “There were some hints in the literature, but we were totally ignorant,” admits Curt Civin, M.D., whose work…...

Read more

Szent-Györgyi Prize Winner Profile Series: Peter Vogt: The Game Changer

The term “game changer” didn’t come into English usage until 1993, and since then it has been driven into the ground from overuse. But when applied to Dr. Peter Vogt, it is more than just hyperbole or overzealous marketing. When you are talking about the person that identified src, the…...

Read more

The Development of Better Ovarian Cancer Biomarkers

“The trouble with ultrasound is that it doesn’t detect many ovarian cancers early,” says Robert Bast, M.D., Vice President for Translational Research at MD Andersen Cancer Center in Houston. Moreover, “Ultrasound doesn’t see really small cancers in the ovary.”...

Read more

The Role of Micronutrients in Battling Cancer

It was largely the work of Helmut Sies, M.D., the esteemed pioneer of oxidative stress whom the National Foundation for Cancer Research (NFCR) supported from 1983 to 2016, that brought the role of micronutrients, including flavonoids, into scientific focus....

Read more

Szent-Györgyi Prize Winner Profile Series: Frederick Alt: It’s Personal

Ask 100 physicians why they got into medicine and you’ll get 100 different answers: Some take the noble route and want to help people, others are just hardwired for it and still others learned early on that potential mates tend to worship doctors (or at least their mothers do!). And…...

Read more